FDA says it is already simplifying access to its IT system, revising SOPs, updating its organizational charts and putting out more guidance documents as recommended in an internal assessment of its inter-center consultation process for combination products released by the agency Oct. 14.
The agency's Office of Planning launched the assessment in 2014 in response to complaints from industry that the product centers within FDA were not effectively coordinating and communicating, leading to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?